BioSpace News Archive

Praj Industries Ltd. and Lygos, Inc. have signed a Memorandum of Understanding to co-develop Lygos’s proprietary yeast for the production of lactic acid.

NTC Srl, an R&D focused pharmaceutical company headquartered in Italy, has granted exclusive license and distribution rights to one of its research and development products, a fixed combination in eye drops, in Israel to Taro Pharmaceutical Industries, a research-based international pharmaceutical company.

CAE announced that its CAE Air1™ ventilator has been certified by Health Canada.

Medscape announced the launch of the Medscape Salary Explorer, a new digital tool delivering up-to-date physician compensation data for virtually every zip code across the U. S.

Mandy Hale, DNP, MSN, MBA, RN, CNN, promoted to new clinical leadership role after 19 years of serving dialysis patients with DaVita

Pougnier brings more than 30 years of global experience as a senior agtech executive to lead the next phase of growth

With novel drug development platform in place, the company deepens pharmaceutical industry expertise and connections

United Therapeutics Corporation announced that key data from the INCREASE study of Tyvaso® Inhalation Solution in patients suffering from World Health Organization Group 3 pulmonary hypertension associated with interstitial lung disease will be presented at a Breaking News Session hosted by the American Thoracic Society on June 24, 2020.

Merck, known as MSD outside the United States and Canada, yesterday priced a $4.5 billion public offering of four series of senior unsecured notes.

Cara Therapeutics, Inc., a biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pruritus by selectively targeting peripheral kappa opioid receptors, or KORs, announced the completion of a planned sample size re-estimation of its KARE Phase 2 dose-ranging trial of Oral KORSUVA for the treatment of moderate-to-severe pruritus in atopic dermatitis patients.